Stem Cell Therapy Shows Promise in Treating Severe Type 1 Diabetes

A groundbreaking stem cell-based treatment has shown remarkable results in a clinical trial. Ten out of twelve patients with the most severe form of Type 1 diabetes no longer require insulin a year after a single infusion. The treatment, developed by Vertex Pharmaceuticals, involves transforming stem cells into pancreatic islet cells to regulate blood glucose. Published in the New England Journal of Medicine, the study represents a significant leap forward, though long-term monitoring of immunosuppressant side effects is needed.